Utilization Management Barriers Among Patients With Cicatricial Alopecia

March 2023 | Volume 22 | Issue 3 | 312 | Copyright © March 2023


Published online February 17, 2023

Katelyn J. Rypka BSa, James T Pathoulas MDa, Kris J. Wharton MSc, Jean R. Pickford BAc, Morinola T. Shobajo BAd, Itisha S. Jefferson BSe, Colleen Leader BAc, Maryanne M. Senna MDf, Ronda S. Farah MDb, Maria K. Hordinsky MDb

aUniversity of Minnesota Medical School Twin Cities, Minneapolis, MN
BDepartment of Dermatology, University of Minnesota, Minneapolis, MN
cScarring Alopecia Foundation, Kulpsville, PA
dUniversity of Illinois College of Medicine, Chicago, IL
eStritch School of Medicine, Loyola University, Chicago, IL
fHarvard Medical School-Massachusetts General Hospital, Department of Dermatology, Boston, MA



Patients with cicatricial alopecia report delayed treatment due to step therapy and other utilization management practices. Most patients are concerned that they are not receiving the right medical therapies due to insurance policies. Our findings align with prior literature reporting step therapy and other utilization management policies are a common barrier to optimal treatment.5

Our results further highlight the negative impact of step therapy. Step therapy protections at the state level have been

Close Menu